The in Vivo and in Vitro Aggregation Properties of Globular Proteins Correlate With Their Conformational Stability: The SH3 Case

Journal of Molecular Biology

Volumn 378, Issue 5, 2008, Pages 1116-1131

  Espargaró, Alba ^a   Castillo, Virginia ^a   de Groot, Natalia S ^a   Ventura, Salvador ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

protein aggregation; protein folding; protein production; protein stability; SH3 domains

Indexed keywords

FODRIN; GLOBULAR PROTEIN; MUTANT PROTEIN; POLYPEPTIDE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ESCHERICHIA COLI; GENE SEQUENCE; IN VITRO STUDY; IN VIVO STUDY; INFRARED SPECTROSCOPY; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN STABILITY;

ESCHERICHIA COLI;

EID: 42649110014     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2008.03.020     Document Type: Article

References (58)

1. S.Y. Tan M.B. Pepys Amyloidosis Histopathology 25 1994 403 414
2. M. Sunde C.C. Blake From the globular to the fibrous state: protein structure and structural conversion in amyloid formation Quart. Rev. Biophys. 31 1998 1 39
3. C.M. Dobson The structural basis of protein folding and its links with human disease Phil. Trans. Roy. Soc. B 356 2001 133 145
4. B. Fahnert H. Lilie P. Neubauer Inclusion bodies: formation and utilisation Adv. Biochem. Eng. Biotechnol. 89 2004 93 142
5. S. Ventura A. Villaverde Protein quality in bacterial inclusion bodies Trends Biotechnol. 24 2006 179 185
6. S. Ventura Sequence determinants of protein aggregation: tools to increase protein solubility Microbial Cell Factories 4 2005 11
7. A.L. Fink Protein aggregation: folding aggregates, inclusion bodies and amyloid Fold. Des. 3 1998 R9 R23
8. U. Rinas F. Hoffmann E. Betiku D. Estape S. Marten Inclusion body anatomy and functioning of chaperone-mediated in vivo inclusion body disassembly during high-level recombinant protein production in Escherichia coli J. Biotechnol. 127 2007 244 257
9. I. Pallares J. Vendrell F.X. Aviles S. Ventura Amyloid fibril formation by a partially structured intermediate state of α-chymotrypsin J. Mol. Biol. 342 2004 321 331
10. J.I. Guijarro M. Sunde J.A. Jones I.D. Campbell C.M. Dobson Amyloid fibril formation by an SH3 domain Proc. Natl Acad. Sci. USA 95 1998 4224 4228
11. M.I. Ivanova M.J. Thompson D. Eisenberg A systematic screen of β(2)-microglobulin and insulin for amyloid-like segments Proc. Natl Acad. Sci. USA 103 2006 4079 4082
12. P. Hammarstrom Y. Sekijima J.T. White R.L. Wiseman A. Lim C.E. Costello D18G transthyretin is monomeric, aggregation prone, and not detectable in plasma and cerebrospinal fluid: a prescription for central nervous system amyloidosis? Biochemistry 42 2003 6656 6663
13. V.J. McParland N.M. Kad A.P. Kalverda A. Brown P. Kirwin-Jones M.G. Hunter Partially unfolded states of β-2-microglobulin and amyloid formation in vitro Biochemistry 39 2000 8735 8746
14. E. Zerovnik M. Skarabot K. Skerget S. Giannini V. Stoka S. Jenko-Kokalj R.A. Staniforth Amyloid fibril formation by human stefin B: influence of pH and TFE on fibril growth and morphology Amyloid 14 2007 237 247
15. S. Ghaemmaghami T.G. Oas Quantitative protein stability measurement in vivo Nature Struct. Biol. 8 2001 879 882
16. N.S. de Groot F.X. Aviles J. Vendrell S. Ventura Mutagenesis of the central hydrophobic cluster in Aβ42 Alzheimer’s peptide. Side-chain properties correlate with aggregation propensities FEBS J. 273 2006 658 668
17. C. Wurth N.K. Guimard M.H. Hecht Mutations that reduce aggregation of the Alzheimer’s Aβ42 peptide: an unbiased search for the sequence determinants of Aβ amyloidogenesis J. Mol. Biol. 319 2002 1279 1290
18. M.A. Speed T. Morshead D.I. Wang J. King Conformation of P22 tailspike folding and aggregation intermediates probed by monoclonal antibodies Protein Sci. 6 1997 99 108
19. M.A. Speed D.I. Wang J. King Specific aggregation of partially folded polypeptide chains: the molecular basis of inclusion body composition Nature Biotechnol. 14 1996 1283 1287
20. G. Calloni S. Zoffoli M. Stefani C.M. Dobson F. Chiti Investigating the effects of mutations on protein aggregation in the cell J. Biol. Chem. 280 2005 10607 10613
21. Z. Ignatova L.M. Gierasch Aggregation of a slow-folding mutant of a β-clam protein proceeds through a monomeric nucleus Biochemistry 44 2005 7266 7274
22. S. Mayer S. Rudiger H.C. Ang A.C. Joerger A.R. Fersht Correlation of levels of folded recombinant p53 in escherichia coli with thermodynamic stability in vitro J. Mol. Biol. 372 2007 268 276
23. Y. Ma L.M. Hendershot The unfolding tale of the unfolded protein response Cell 107 2001 827 830
24. A. Musacchio M. Noble R. Pauptit R. Wierenga M. Saraste Crystal structure of a Src-homology 3 (SH3) domain Nature 359 1992 851 855
25. J.C. Martinez A.R. Viguera R. Berisio M. Wilmanns P.L. Mateo V.V. Filimonov L. Serrano Thermodynamic analysis of α-spectrin SH3 and two of its circular permutants with different loop lengths: discerning the reasons for rapid folding in proteins Biochemistry 38 1999 549 559
26. J.C. Martinez L. Serrano The folding transition state between SH3 domains is conformationally restricted and evolutionarily conserved Nature Struct. Biol. 6 1999 1010 1016
27. V.P. Grantcharova D.S. Riddle J.V. Santiago D. Baker Important role of hydrogen bonds in the structurally polarized transition state for folding of the src SH3 domain Nature Struct. Biol. 5 1998 714 720
28. S. Ventura M.C. Vega E. Lacroix I. Angrand L. Spagnolo L. Serrano Conformational strain in the hydrophobic core and its implications for protein folding and design Nature Struct. Biol. 9 2002 485 493
29. J.C. Martinez M.T. Pisabarro L. Serrano Obligatory steps in protein folding and the conformational diversity of the transition state Nature Struct. Biol. 5 1998 721 729
30. M.C. Vega J.C. Martinez L. Serrano Thermodynamic and structural characterization of Asn and Ala residues in the disallowed II′ region of the Ramachandran plot Protein Sci. 9 2000 2322 2328
31. M. Carrio N. Gonzalez-Montalban A. Vera A. Villaverde S. Ventura Amyloid-like properties of bacterial inclusion bodies J. Mol. Biol. 347 2005 1025 1037
32. G.D. Davis C. Elisee D.M. Newham R.G. Harrison New fusion protein systems designed to give soluble expression in Escherichia coli Biotechnol. Bioeng. 65 1999 382 388
33. E. Garcia-Fruitos N. Gonzalez-Montalban M. Morell A. Vera R. Ferraz A. Aris Aggregation as bacterial inclusion bodies does not imply inactivation of enzymes and fluorescent proteins Microb. Cell Fact. 4 2005 27
34. N.S. de Groot S. Ventura Protein activity in bacterial inclusion bodies correlates with predicted aggregation rates J. Biotechnol. 125 2006 110 113
35. N.S. de Groot S. Ventura Effect of temperature on protein quality in bacterial inclusion bodies FEBS Lett. 580 2006 6471 6476
36. C.H. Luan S. Qiu J.B. Finley M. Carson R.J. Gray W. Huang High-throughput expression of C. elegans proteins Genome Res. 14 2004 2102 2110
37. C.S. Goh N. Lan S.M. Douglas B. Wu N. Echols A. Smith Mining the structural genomics pipeline: identification of protein properties that affect high-throughput experimental analysis J. Mol. Biol. 336 2004 115 130
38. S. Idicula-Thomas A.J. Kulkarni B.D. Kulkarni V.K. Jayaraman P.V. Balaji A support vector machine-based method for predicting the propensity of a protein to be soluble or to form inclusion body on overexpression in Escherichia coli Bioinformatics 22 2006 278 284
39. S. Idicula-Thomas P.V. Balaji Understanding the relationship between the primary structure of proteins and its propensity to be soluble on overexpression in Escherichia coli Protein Sci. 14 2005 582 592
40. M.I. Ivanova M.R. Sawaya M. Gingery A. Attinger D. Eisenberg An amyloid-forming segment of β2-microglobulin suggests a molecular model for the fibril Proc. Natl Acad. Sci. USA 101 2004 10584 10589
41. S. Ventura J. Zurdo S. Narayanan M. Parreno R. Mangues B. Reif Short amino acid stretches can mediate amyloid formation in globular proteins: the Src homology 3 (SH3) case Proc. Natl Acad. Sci. USA 101 2004 7258 7263
42. F. Bemporad G. Calloni S. Campioni G. Plakoutsi N. Taddei F. Chiti Sequence and structural determinants of amyloid fibril formation Accts Chem. Res. 39 2006 620 627
43. A. Caflisch Computational models for the prediction of polypeptide aggregation propensity Curr. Opin. Chem. Biol. 10 2006 437 444
44. O. Conchillo-Sole N.S. de Groot F.X. Aviles J. Vendrell X. Daura S. Ventura AGGRESCAN: a server for the prediction and evaluation of “hot spots” of aggregation in polypeptides BMC Bioinformatics 8 2007 65
45. A.M. Fernandez-Escamilla F. Rousseau J. Schymkowitz L. Serrano Prediction of sequence-dependent and mutational effects on the aggregation of peptides and proteins Nature Biotechnol. 22 2004 1302 1306
46. F. Chiti M. Stefani N. Taddei G. Ramponi C.M. Dobson Rationalization of the effects of mutations on peptide and protein aggregation rates Nature 424 2003 805 808
47. S. Ventura E. Lacroix L. Serrano Insights into the origin of the tendency of the PI3-SH3 domain to form amyloid fibrils J. Mol. Biol. 322 2002 1147 1158
48. B. Morel S. Casares F. Conejero-Lara A single mutation induces amyloid aggregation in the α-spectrin SH3 domain: analysis of the early stages of fibril formation J. Mol. Biol. 356 2006 453 468
49. M. Dumoulin D. Canet A.M. Last E. Pardon D.B. Archer S. Muyldermans Reduced global cooperativity is a common feature underlying the amyloidogenicity of pathogenic lysozyme mutations J. Mol. Biol. 346 2005 773 788
50. Y. Kim J.S. Wall J. Meyer C. Murphy T.W. Randolph M.C. Manning Thermodynamic modulation of light chain amyloid fibril formation J. Biol. Chem. 275 2000 1570 1574
51. M. Ramirez-Alvarado J.S. Merkel L. Regan A systematic exploration of the influence of the protein stability on amyloid fibril formation in vitro Proc. Natl Acad. Sci. USA 97 2000 8979 8984
52. D.P. Smith S. Jones L.C. Serpell M. Sunde S.E. Radford A systematic investigation into the effect of protein destabilisation on beta 2-microglobulin amyloid formation J. Mol. Biol. 330 2003 943 954
53. D.J. Selkoe Folding proteins in fatal ways Nature 426 2003 900 904
54. D.R. Booth M. Sunde V. Bellotti C.V. Robinson W.L. Hutchinson P.E. Fraser Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis Nature 385 1997 787 793
55. M. Takeuchi M. Mizuguchi T. Kouno Y. Shinohara T. Aizawa M. Demura Destabilization of transthyretin by pathogenic mutations in the DE loop Proteins: Struct. Funct. Genet. 66 2007 716 725
56. F.E. Cohen J.W. Kelly Therapeutic approaches to protein-misfolding diseases Nature 426 2003 905 909
57. S.C. Gill P.H. Von Hippel Calculation of protein extinction coefficients from amino acid sequence data Anal. Biochem. 182 1989 319 326
58. W.E. Klunk J.W. Pettegrew D.J. Abraham Quantitative evaluation of congo red binding to amyloid-like proteins with a beta-pleated sheet conformation J. Histochem. Cytochem. 37 1989 1273 1281